Relative to valuation - I think the exosome kits sales are very significant - if they start pulling in $millions / possibly $10's millions in revnue - through just this aspect of the business - it will transform the standing of IIQ - and put a rocket under the SP - exosome kits have a very strong pipeline of opportunity - as research is moving in this direction
Screening for cancers is another dimension - if IIQ get this going the SP will go parabolic
Ann: INOVIQ and Promega announce Global Joint Marketing Agreement, page-14
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
-0.010(1.75%) |
Mkt cap ! $59.09M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 57.0¢ | 54.0¢ | $96.73K | 176.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12 | 55.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.0¢ | 7999 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |